2002
DOI: 10.1177/152660280200900116
|View full text |Cite
|
Sign up to set email alerts
|

Renal Infarction following Endovascular Aortic Aneurysm Repair: Incidence and Clinical Consequences

Abstract: Documented renal infarctions following endovascular aortic stent-graft placement are not common and do not appear to be associated with suprarenal endograft fixation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
49
0
4

Year Published

2003
2003
2019
2019

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(57 citation statements)
references
References 23 publications
3
49
0
4
Order By: Relevance
“…We were unable to contact the authors for clarification so this series was excluded. 24 The remaining 11 studies were eligible for the meta-analysis. ‡ Study characteristics and quality.…”
Section: Resultsmentioning
confidence: 99%
“…We were unable to contact the authors for clarification so this series was excluded. 24 The remaining 11 studies were eligible for the meta-analysis. ‡ Study characteristics and quality.…”
Section: Resultsmentioning
confidence: 99%
“…The presence of renal dysfunction after EVAR with suprarenal fixation appears to be multifactorial and transient in most patients. 285 Nonetheless, renal artery occlusion and infarctions have been reported in patients with preexisting renal artery occlusive disease 286,287 and, while infrequent, visceral dysfunction and celiac or mesentery artery occlusion may occur secondary to suprarenal fixation. 288,289 Recommended management of the internal iliac artery.…”
Section: Endovascular Repairmentioning
confidence: 99%
“…In a retrospective comparison of endografts with transrenal fixation to those with infrarenal fixation only, transrenal fixation was associated with a trend for higher incidence of small renal infarcts, but with no short-or mid-term impairment of renal function.3 Similarly, in a study that included 99 patients with Vanguard (Boston Scien-tific Corp., Natick, Mass), Talent (Medtronic, Sunnyvale, Calif), Excluder (Gore and Assoc, Flagstaff, Ariz), Corvita (Boston Scientific Corp), AneuRx, Lifepath (Baxter Healthcare, Irvine, Calif), and Zenith (Cook Inc., Bloomington, Indiana) devices, renal infarction rate was 8.7% in 69 renal arteries with bare stents extending through the ostium, and 5.6% in the 124 arteries with infrarenal fixation alone. 4 In large clinical series of EVAR, renal artery coverage is reported to occur with less than 1% frequency. In 128 patients treated with the AneuRx device, one suprarenal deployment occurred, which was corrected with intraoperative repositioning of the fully deployed endograft.6 Neither accidental renal artery coverage nor any secondary interventions for renal complications were reported in two other series of 179 and 239 EVAR with a variety of different endografts.7,8 In another series, homemade and Talent-LPS transrenal devices were used in 192 patients and renal artery coverage by the graft material was reported only in 2 cases.…”
Section: Discussionmentioning
confidence: 99%